Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Alfasigma acquires Nordic Pharma for global expansion

PRIVATEAug 15, 2026•about 6 hours ago

Acquiring Company

Alfasigma

Acquired Company

Nordic Pharma

Bologna

BerwynManufacturingBiotechnologyHealth CareBiotechnologyHealth Care

Description

Alfasigma has announced its acquisition of Nordic Pharma to enter the Japanese and Canadian markets. The Italian drugmaker aims to enhance its global portfolio with Nordic Pharma's specialized products in rheumatology and women's health. The deal, valued at an undisclosed amount, is expected to close before the end of 2026, pending regulatory approval. This acquisition aligns with Alfasigma's strategy of targeting smaller pharmaceutical firms for growth.

Company Information

Company

Alfasigma

Location

Bologna, Emilia Romagna, Italy

About

Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. The Group has a worldwide presence in over 100 countries where about 3000 people work in research, development, production and distribution. In Italy, Alfasigma is a leader in the prescription products market where, in addition to its strong focus on gastro-intestinal products, it is present in several primary care therapeutic areas. It is popular with the consumer public for a number of nutraceuticals & food supplements that respond to different needs, and that are well known and deeply rooted in the Italian families experience. Its historical headquarters is in Bologna, to which is added Milan, while the production sites are: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa in Spain and in Shreveport (Louisiana) in the United States. The R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo. Alfasigma's mission is to improve people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.

Don't miss Alfasigma's next move

Get an email the moment Alfasigma makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Alfasigma's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Nordic Pharma?

Nordic Pharma was acquired by Alfasigma, based in Bologna. The deal was reported on August 15, 2026. Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. Alfasigma is privately held and operates in Manufacturing.

When did Alfasigma acquire Nordic Pharma?

Alfasigma's acquisition of Nordic Pharma was reported on August 15, 2026. Alfasigma has announced its acquisition of Nordic Pharma to enter the Japanese and Canadian markets. The Italian drugmaker aims to enhance its global portfolio with Nordic Pharma's specialized products in rheumatology and women's health. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Nordic Pharma do?

Nordic Pharma, Inc. is committed to engaging ophthalmologists and optometrists in the early launch stages of LACRIFILL Canalicular Gel. It is privately held, operating in Biotechnology, and is based in Berwyn.